Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.65 |
| ▸ | CA1 | P00915 | 4/20 | 0.65 |
| ▸ | PPARA | Q07869 | 4/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.57 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | ADH1B | P00325 | 1/20 | 0.46 |
| ▸ | ADH1C | P00326 | 1/20 | 0.46 |
| ▸ | ADH1A | P07327 | 1/20 | 0.46 |
| ▸ | ADH4 | P08319 | 1/20 | 0.46 |
| ▸ | ADH7 | P40394 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1704524 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1728204 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL8359336 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL28620941 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1726845 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1726881 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL7757406 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1704123 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1704122 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 | |
| SCHEMBL1704523 | 1.00 | CA2 (0.65) | CA2CA1PPARAEPHX1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117613252-B | Silicon-carbon composite material for lithium ion battery with high specific energy density and preparation method thereof | 云南坤天新能源有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117613252-A | Silicon-carbon composite material for lithium ion battery with high specific energy density and preparation method thereof | 云南坤天新能源有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-110099681-A | For treating the composition and method of xerostomia | 塞尔利克斯生物私人有限公司 | 2019-08-06 | — | — | CN | claimed |
| EP-0456177-A1 | Hydrocarbon soluble sulfonic or sulfamic acids as charge adjuvants for positive electrostatic liquid developers | DXIMAGING (US) | 1991-11-13 | — | — | EP | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-117613252-B | Silicon-carbon composite material for lithium ion battery with high specific energy density and preparation method thereof | 云南坤天新能源有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024073025-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| CN-107209146-B | Electrochemical gas sensor and electrolyte for electrochemical gas sensor | 德尔格安全股份两合公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-117613252-A | Silicon-carbon composite material for lithium ion battery with high specific energy density and preparation method thereof | 云南坤天新能源有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-113252759-A | Electrochemical gas sensor and electrolyte for electrochemical gas sensor | 德尔格安全股份两合公司 | 2021-08-13 | — | — | CN | disclosed |
| EP-0047546-A2 | A new method of preparing 3-(2-hydroxy-2-arylethyl)-2-iminothiazolidines | JANSSEN PHARMACEUTICA N.V. (BE) | 1982-03-17 | — | — | EP | disclosed |
| US-4260560-A | HALOGENATING A SULFAMIC ACID IN PRESENCE OF PHOSPHORUS OR PHOSPHORUS TRIHALIDE | BASF AKTIENGESELLSCHAFT (DE) | 1981-04-07 | — | — | US | disclosed |
| EP-0009362-A1 | Heterocyclic derivatives of guanidine, their preparation and pharmaceutical formulations comprising them | McNeilab, Inc. (US) | 1980-04-02 | — | — | EP | disclosed |
| US-4104298-A | FROM SULFAMIC ACIDS AND PHOSPHORUS PENTAHALIDES | BASF AKTIENGESELLSCHAFT (DE) | 1978-08-01 | — | — | US | disclosed |
| US-4101571-A | REACTING SULFAMIC ACIDS WITH PHOSGENE | BASF AKTIENGESELLSCHAFT (DE) | 1978-07-18 | — | — | US | disclosed |
| US-4096181-A | Substituted sulfamic acid halides | BASF AKTIENGESELLSCHAFT (DT) | 1978-06-20 | — | — | US | disclosed |
| US-4049709-A | Vinyl-substituted sulfamic acid halides | BASF AKTIENGESELLSCHAFT (DT) | 1977-09-20 | — | — | US | disclosed |
| US-3992444-A | BY REACTION OF A SULFAMIC ACID WITH AN ACID HALIDE | BASF AKTIENGESELLSCHAFT (DT) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | CA2 3201/4885CA1 3912/4885PPARA 1111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.